# Dosing of Ketorolac Impacts Post-cesarean paiN manaGemenet (KING)

> **NCT05248984** · PHASE4 · COMPLETED · sponsor: **Ohio State University** · enrollment: 92 (actual)

## Conditions studied

- Post Cesarean Pain

## Interventions

- **DRUG:** Ketorolac 30 Mg
- **DRUG:** Ketorolac 60 Mg

## Key facts

- **NCT ID:** NCT05248984
- **Lead sponsor:** Ohio State University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-06-08
- **Primary completion:** 2023-11-30
- **Final completion:** 2023-11-30
- **Target enrollment:** 92 (ACTUAL)
- **Last updated:** 2026-02-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05248984

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05248984, "Dosing of Ketorolac Impacts Post-cesarean paiN manaGemenet (KING)". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05248984. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*